Regulatory Mark

Regulatory Mark is obsessed with medical device development. We offer regulatory and quality solutions to expedite your product’s path to market.

[Regulatory Mark @RegulatoryMark]

Cybersecurity threats can lead to recalls. Make sure your cybersecurity plan is appropriate throughout your product lifecycle!

[Media Affairs @FDAMedia]

FDA is warning about certain Medtronic insulin pumps being recalled due to potential cybersecurity risks. Patients should switch to models better equipped to protect against the risks. https://t.co/9UTri5wI8V

[Regulatory Mark @RegulatoryMark]

Is your CBD product a drug, cosmetic, or nutritional supplement? It may be depending on your claims; make sure they’re in alignment with FDA regulation! https://t.co/gBPGizZE5K

[Regulatory Mark @RegulatoryMark]

FDA is focused on usability. Make sure your submission contains the right information!

[FDA Medical Devices @FDADeviceInfo]

The National Evaluation System for health Technology (NEST) works to more efficiently generate better evidence for medical device evaluation and regulatory decision-making.

[Enable Injections @EnableInjection]

Cincinnati is Home to a Robust Life Sciences Ecosystem, new article on great companies like @GenetesisInc, @eccrinesystems, CinCor, Aerpio, @GeneSight, & @BexionPharma. Thank you, @biospace, for the mention! https://t.co/Gjc9zUybi1 #Cincinnati #startups

[FDA Law Blog @fdalawblog]

FDA’s Pre-Cert Program Enters its Testing Phase - https://t.co/QSSzkAQ5Tk

[Regulatory Mark @RegulatoryMark]

Quality control and supplier audits done correctly save time and money in the long run. Make sure your QMS has the right processes in place to stop problems before they start! https://t.co/YSZ0A2osZr

[MedPage Today @medpagetoday]

Problems with surgical staplers that came to light last month are now being addressed by the @US_FDA, the agency said.
https://t.co/8T7GmRLwRt

[Nicholas Florko @NicholasFlorko]

An FDA scooplet: The agency has got a new director for it's Office of Regulatory Policy, and its Pew's Elizabeth Jungman. That's a powerful office perhaps best known for its role regulating compounding. More here for Plus subs:

https://t.co/q4icS1UqoT

[Regulatory Mark @RegulatoryMark]

New to medical device industry? Are you a founder who needs a basic understanding of regulatory? Attend the Regulatory Education for Industry (REdI) Annual Conference May 29-30, 2019 #FDA #cdrh #medicaldevice https://t.co/AOKdivb4l9

[Regulatory Mark @RegulatoryMark]

Press Announcements > FDA permits marketing of first medical device for treatment of ADHD https://t.co/WvLxJDPjiN

[Regulatory Mark @RegulatoryMark]

Thanks @ODTmagazine for the in depth exploration of orthopedic tech. It was such a pleasure connecting with colleagues and discussing regulatory considerations in software!

[FDA Law Blog @fdalawblog]

FDA Announces 5/16 Meeting on Responsible Innovation in Dietary Supplements - https://t.co/NxbDXuiZDs

[FDA/CDRH Industry @FDAcdrhIndustry]

Read the FDA’s new discussion paper on a potential #TPLC approach to regulating #artificialintelligence and #machinelearning software as a medical device https://t.co/lmEwqhX5Ns #digitalhealth #healthtech

[Regulatory Mark @RegulatoryMark]

Regulatory Mark is looking to hire! If you have medical device regulatory experience DM us or email us at [email protected]. We hope to hear from you soon!

[Regulatory Mark @RegulatoryMark]

Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on efforts to evaluate materials in medical devices to address potential safety questions https://t.co/4PG8rW2ttc

[Criterion Edge @CriterionEdge]

There's widespread frustration over the progress in #notifiedbody designations. TEAM-NB warns that it won't be able to assess all applications before the 2020 #MDR deadline. #Medtech Europe says that members are prepared, but the #regulatory system is not. https://t.co/D9boQhunrc

[Dr. Anthony Letai @NCIDirector]

(1/3) Change is good, but bittersweet. It is difficult for me to say goodbye to @theNCI family as I head to @FDA to serve as acting commissioner. Rest assured that our shared goals for patients and the public’s health will translate into my new duties.

[Regulatory Mark @RegulatoryMark]

We regularly direct clients who want to learn more on their own to CDRH Learn - a great tool to learn FDA basics - check it out! #fda #Medicaldevices https://t.co/GYaDUed0H1

[Elevate International Management @elevateinter]

No longer artificial – AI in Pharma and Healthcare #pharma #health #healthcare #pharmaceutical #medtech #healthtech #Sales #marketing #tech
https://t.co/iB5UErZGFB